TP53 and colorectal carcinoma: Based on the sequencing data of CRC cell lines (HCT116, RKO and SW48) that were untreated or treated with a DNA-damaging agent, circ-MDM2 was selected as the target circRNA, the expression of which was altered upon DNA damage and dependent on p53.